Pharmaceutical formulation having enhanced bile acid binding affinity
US5569452A · kind A · utility
15Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 30, 1995 |
| Grant date | Oct 29, 1996 |
| Priority date | — |
| Expiry date | May 30, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/38
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical formulation comprising a polymeric resin having bile acid binding properties in combination with at least one bile acid binding material which enhances the bile acid binding affinity and/or capacity of the formulation, methods for preparing the formulations and methods for using the formulations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.